Akoya Biosciences, Inc. (NASDAQ:AKYA), The Spatial Biology Company®, and Shanghai KR Pharmtech, a leading company providing molecular diagnostic solutions in China, have jointly announced that KR-HT5, which Akoya
Tesla Inc. (NASDAQ: TSLA) on Friday evening presented a prototype of its humanoid under development — the Optimus bot.
The bot is designed to be “extremely used” and production is aimed at volumes.